Free Trial

Leerink Partnrs Research Analysts Lift Earnings Estimates for agilon health, inc. (NYSE:AGL)

→ Dividend-like income from non-dividend stocks (From Unstoppable Prosperity) (Ad)

agilon health, inc. (NYSE:AGL - Free Report) - Analysts at Leerink Partnrs raised their Q1 2025 earnings per share estimates for agilon health in a research report issued on Wednesday, May 8th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.08 per share for the quarter, up from their prior forecast of $0.04. The consensus estimate for agilon health's current full-year earnings is ($0.33) per share.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the prior year, the business earned ($0.14) earnings per share. The firm's quarterly revenue was up 71.8% on a year-over-year basis.

A number of other equities analysts have also issued reports on the company. Stifel Nicolaus lowered their price target on agilon health from $8.00 to $7.00 and set a "hold" rating on the stock in a report on Wednesday, May 1st. Royal Bank of Canada lowered their price target on agilon health from $11.00 to $8.00 and set an "outperform" rating on the stock in a report on Wednesday, February 28th. Evercore ISI lowered their price target on agilon health from $7.00 to $6.00 and set an "in-line" rating on the stock in a report on Wednesday, February 28th. Barclays initiated coverage on agilon health in a report on Wednesday, March 6th. They set an "underweight" rating and a $5.00 price target on the stock. Finally, Benchmark lowered their price target on agilon health from $13.00 to $9.00 and set a "buy" rating on the stock in a report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of "Hold" and an average price target of $9.32.


Get Our Latest Report on AGL

agilon health Stock Performance

Shares of AGL stock traded down $0.07 during mid-day trading on Friday, hitting $5.19. 2,089,584 shares of the stock were exchanged, compared to its average volume of 5,543,419. The stock's fifty day simple moving average is $5.31 and its two-hundred day simple moving average is $8.64. The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of -8.09 and a beta of 0.52. agilon health has a 12-month low of $4.41 and a 12-month high of $26.15. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.51 and a current ratio of 1.51.

Institutional Trading of agilon health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Signaturefd LLC increased its holdings in agilon health by 73.7% in the third quarter. Signaturefd LLC now owns 1,673 shares of the company's stock valued at $30,000 after buying an additional 710 shares during the last quarter. Quest Partners LLC bought a new position in shares of agilon health during the fourth quarter valued at approximately $45,000. Neo Ivy Capital Management bought a new position in shares of agilon health during the fourth quarter valued at approximately $47,000. Van ECK Associates Corp grew its holdings in shares of agilon health by 164.7% during the third quarter. Van ECK Associates Corp now owns 4,111 shares of the company's stock valued at $73,000 after purchasing an additional 2,558 shares during the last quarter. Finally, Covestor Ltd grew its holdings in shares of agilon health by 1,439.6% during the third quarter. Covestor Ltd now owns 5,912 shares of the company's stock valued at $105,000 after purchasing an additional 5,528 shares during the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Earnings History and Estimates for agilon health (NYSE:AGL)

→ Bitcoin’s Biggest Year Yet (From Paradigm Press) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: